Zusammenfassung
Erläutert werden alle relevanten Funktionstests mit ausführlicher Darstellung von Indikationen, Kontraindikationen, Nebenwirkungen, Testvorbereitung, Rahmenbedingungen, konkreten Handlungsanleitung der eigentlichen Testdurchführung sowie der Interpretation der Testergebnisse. Es werden immer konkrete Normbereiche und Cut-off-Werte angegeben, auch für besondere Situationen (Geschlecht, Alter, BMI, Pubertätsphasen, Zyklusphasen, akute Erkrankungen, Medikamente etc.). Ein besonderes Merkmal ist die Betonung der Testvorbereitung, -durchführung und -interpretation sowie des interdisziplinären Charakters. Gegliedert nach Zona reticularis, Zona fasciculata und Zona glomerulosa werden Nebennierenrinden-Erkrankungen im Hinblick auf die funktionelle Testdiagnostik abgehandelt. Dieses Kapitel ist von eminenter Bedeutung für die endokrinologische Diagnostik per se und ist charakterisiert durch sehr viele verschiedene, teils sehr anspruchsvolle Testverfahren bis hin zum Nebennierenvenen-Katheter. Medikamenteninteraktionen und Interpretation der Testdiagnostik spielen eine praxisrelevante Rolle, ebenso wie die Unterscheidung zwischen Screening-, Bestätigungs- und Lokalisationstests.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing’s syndrome. J Clin Endocrinol Metab 89:1222–1226
Pecori Giraldi F, Ambrogio AG, De Martin M, Fatti LM, Scacchi M, Cavagnini F (2007) Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J Clin Endocrinol Metab 92:4123–4129
Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 88:5299–5306
Reimondo G, Paccotti P, Minetto M, Termine A, Stura G, Bergui M, Angeli A, Terzolo M (2003) The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing’s syndrome. Clin Endocrinol (Oxf) 58:718–724
Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M (2005) Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol 153:803–809
Papanicolaou DA, Mullen N, Kyrou I, Nieman LK (2002) Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 87:4515–4521
Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266–3281
Diederich S, Bidlingmaier M, Quinkler M, Reincke M (2007) Diagnosis of primary hyperaldosteronism. Med Klin (Munich) 102:16–21
Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill JR Jr (2000) Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 85:4526–4533
Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ (2003) Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 88:3637–3644
Holland OB, Brown H, Kuhnert L, Fairchild C, Risk M, Gomez-Sanchez CE (1984) Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6:717–723
Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M (2006) Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 91:2618–2623
Schirpenbach C, Seiler L, Maser-Gluth C, Rudiger F, Nickel C, Beuschlein F, Reincke M (2006) Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol 154:865–873
Kem DC, Weinberger MH, Mayes DM, Nugent CA (1971) Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 128:380–386
Young WF (2007) Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607–618
Stowasser M, Gordon RD (2004) Primary aldosteronism: careful investigation is essential and rewarding. Mol Cell Endocrinol 217:33–39
Lim PO, Farquharson CA, Shiels P, Jung RT, Struthers AD, MacDonald TM (2001) Adverse cardiac effects of salt with fludrocortisone in hypertension. Hypertension 37:856–861
Giacchetti G, Mulatero P, Mantero F, Veglio F, Boscaro M, Fallo F (2008) Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. Trends Endocrinol Metab 19:104–108
Lyons DF, Kem DC, Brown RD, Hanson CS, Carollo ML (1983) Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 57:892–896
Castro OL, Yu X, Kem DC (2002) Diagnostic value of the post-captopril test in primary aldosteronism. Hypertension 39:935–938
Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC, Mantero F (2007) Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50:424–431
Agharazii M, Douville P, Grose JH, Lebel M (2001) Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37:1440–1443
Mulatero P, Bertello C, Garrone C, Rossato D, Mengozzi G, Verhovez A, Fallo F, Veglio F (2007) Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 50:e26–e27
Rossi GP, Seccia TM, Pessina AC (2008) Primary aldosteronism: part II: subtype differentiation and treatment. J Nephrol 21:455–462
Rossi GP, Ganzaroli C, Miotto D, De Toni R, Palumbo G, Feltrin GP, Mantero F, Pessina AC (2006) Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 24:371–379
Gordon RD (1995) Primary aldosteronism. J Endocrinol Invest 18:495–511
Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247:511–518
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Schäffler, A. et al. (2018). Nebennierenrinde. In: Schäffler, A. (eds) Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55914-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-55914-7_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55913-0
Online ISBN: 978-3-662-55914-7
eBook Packages: Medicine (German Language)